Application no. and date | 17788792.4 (espacenet) (Federated) (European Patent Register), 20170427 | Patent/reg. no. and date | DK/EP 3447051, 20211215 | Publication date | 20190227 | Priority no. and date | CN 201610274566, 20160428 | EP pub. no. and date |
EP 3447051 20190227 | Effective date | | Applicant/owner | Jiangsu Hengrui Medicine Co., Ltd., No. 7 Kunlunshan Road Economic and Technological Development Zone Lianyungang
Jiangsu 222047, CN | Applicant ref. no. | BBS180242EPDK | Inventor | WU, Guaili, No.7 Kunlunshan Road Economic and Technological Development Zone Lianyungang
Jiangsu 222047, CN, ZHANG, Quanliang, No.7 Kunlunshan Road Economic and Technological Development Zone Lianyungang
Jiangsu 222047, CN, CAO, Yongxing, No.7 Kunlunshan Road Economic and Technological Development Zone Lianyungang
Jiangsu 222047, CN | Representative | Novagraaf Brevets, Bâtiment O2, 2 rue Sarah Bernhardt CS90017
F-92665 Asnières-sur-Seine cedex, FR | Opponent | | IPC Class | C07D 207/08 (2006.01) , C07D 207/16 (2006.01) , C07D 401/12 (2006.01) , C07D 401/14 (2006.01) | Title | FREMGANGSMÅDE TIL FREMSTILLING AF TYROSINKINASEINHIBITOR OG DERIVAT DERAF | Int. application no. | CN2017082164 | Int. publication no. | WO2017186140 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|